References
- Pijls NH, De Bruyne B, Peels K et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N. Engl. J. Med.334, 1703–1708 (1996).
- Bech GJ, De Bruyne B, Pijls NH et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation103, 2928–2934 (2001).
- Pijls NH, van Schaardenburgh P, Manoharan G et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J. Am. Coll. Cardiol.49, 2105–2111 (2007).
- Moses JW, Stone GW, Nikolsky E et al. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J. Am. Coll. Cardiol.47, 2164–2171 (2006).
- Tonino PA, De Bruyne B, Pijls NH et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med.360, 213–224 (2009).
- Botman KJ, Pijls NH, Bech JW et al. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement. Catheter Cardiovasc. Interv.63, 184–191 (2004).
- Serruys PW, Morice MC, Kappetein AP et al.; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med.360, 961–972 (2009).
- Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med.356, 1503–1516 (2007).
- Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation117, 1283–1291 (2008).